BACKGROUND: Apolipoprotein E (apoE) has been shown to play a pivotal role in the development of cardiovascular disease, attributable to its function in lipid trafficking and immune modulating properties; however, its role in modulating inflammation in the setting of acute lung injury (ALI) is unknown. OBJECTIVE: To determine whether apoE-deficient mice (apoE-/-) are more susceptible to ALI compared to wild-type (WT) animals. METHODS: Two independent models of ALI were employed. Firstly, WT and apoE-/- mice were randomized to acid aspiration (50 μl of 0.1 N hydrochloric acid) followed by 4 h of mechanical ventilation. Secondly, WT and apoE-/- mice were randomized to 72 h of hyperoxia exposure or room air. Thereafter, the intrinsic responses of WT and apoE-/- mice were assessed using the isolated perfused mouse lung (IPML) setup. Finally, based on elevated levels of oxidized low-density lipoprotein (oxLDL) in apoE-/-, the effect of oxLDL on lung endothelial permeability and inflammation was assessed. RESULTS: In both in vivo models, apoE-/- mice demonstrated greater increases in lung lavage protein levels, neutrophil counts, and cytokine expression (p < 0.05) compared to WT mice. Experiments utilizing the IPML setup demonstrated no differences in intrinsic lung responses to injury between apoE-/- and WT mice, suggesting the presence of a circulating factor as being responsible for the in vivo observations. Finally, the exposure of lung endothelial cells to oxLDL resulted in increased monolayer permeability and IL-6 release compared to native (nonoxidized) LDL. CONCLUSIONS: Our findings demonstrate a susceptibility of apoE-/- animals to ALI that may occur, in part, due to elevated levels of oxLDL.
BACKGROUND:Apolipoprotein E (apoE) has been shown to play a pivotal role in the development of cardiovascular disease, attributable to its function in lipid trafficking and immune modulating properties; however, its role in modulating inflammation in the setting of acute lung injury (ALI) is unknown. OBJECTIVE: To determine whether apoE-deficient mice (apoE-/-) are more susceptible to ALI compared to wild-type (WT) animals. METHODS: Two independent models of ALI were employed. Firstly, WT and apoE-/-mice were randomized to acid aspiration (50 μl of 0.1 N hydrochloric acid) followed by 4 h of mechanical ventilation. Secondly, WT and apoE-/-mice were randomized to 72 h of hyperoxia exposure or room air. Thereafter, the intrinsic responses of WT and apoE-/-mice were assessed using the isolated perfused mouse lung (IPML) setup. Finally, based on elevated levels of oxidized low-density lipoprotein (oxLDL) in apoE-/-, the effect of oxLDL on lung endothelial permeability and inflammation was assessed. RESULTS: In both in vivo models, apoE-/-mice demonstrated greater increases in lung lavage protein levels, neutrophil counts, and cytokine expression (p < 0.05) compared to WT mice. Experiments utilizing the IPML setup demonstrated no differences in intrinsic lung responses to injury between apoE-/- and WT mice, suggesting the presence of a circulating factor as being responsible for the in vivo observations. Finally, the exposure of lung endothelial cells to oxLDL resulted in increased monolayer permeability and IL-6 release compared to native (nonoxidized) LDL. CONCLUSIONS: Our findings demonstrate a susceptibility of apoE-/- animals to ALI that may occur, in part, due to elevated levels of oxLDL.
Authors: Jesús Villar; Jesús Blanco; José Manuel Añón; Antonio Santos-Bouza; Lluís Blanch; Alfonso Ambrós; Francisco Gandía; Demetrio Carriedo; Fernando Mosteiro; Santiago Basaldúa; Rosa Lidia Fernández; Robert M Kacmarek Journal: Intensive Care Med Date: 2011-10-14 Impact factor: 17.440
Authors: Melissa G Walker; Li-Juan Yao; Eric K Patterson; Mariamma G Joseph; Gediminas Cepinskas; Ruud A W Veldhuizen; James F Lewis; Cory M Yamashita Journal: Respiration Date: 2011-02-09 Impact factor: 3.580
Authors: V M Ranieri; P M Suter; C Tortorella; R De Tullio; J M Dayer; A Brienza; F Bruno; A S Slutsky Journal: JAMA Date: 1999-07-07 Impact factor: 56.272
Authors: Lesly A Dossett; Daithi Heffernan; Michelle Lightfoot; Bryan Collier; Jose J Diaz; Robert G Sawyer; Addison K May Journal: Chest Date: 2008-08-21 Impact factor: 9.410
Authors: E K Patterson; L J Yao; N Ramic; J F Lewis; G Cepinskas; L McCaig; R A W Veldhuizen; C M Yamashita Journal: Mediators Inflamm Date: 2013-03-27 Impact factor: 4.711
Authors: Amisha V Barochia; Maryann Kaler; Rosemarie A Cuento; Elizabeth M Gordon; Nargues A Weir; Maureen Sampson; Joseph R Fontana; Sandra MacDonald; Joel Moss; Vincent Manganiello; Alan T Remaley; Stewart J Levine Journal: Am J Respir Crit Care Med Date: 2015-05-01 Impact factor: 21.405
Authors: M Kristen Demoruelle; Emily Bowers; Lauren J Lahey; Jeremy Sokolove; Monica Purmalek; Nickie L Seto; Michael H Weisman; Jill M Norris; Mariana J Kaplan; V Michael Holers; William H Robinson; Kevin D Deane Journal: Arthritis Rheumatol Date: 2018-03-02 Impact factor: 10.995
Authors: Cory M Yamashita; Candice Cybulskie; Scott Milos; Yi Y Zuo; Lynda A McCaig; Ruud A W Veldhuizen Journal: Can J Physiol Pharmacol Date: 2016-01-19 Impact factor: 2.273
Authors: Xianglan Yao; Elizabeth M Gordon; Debbie M Figueroa; Amisha V Barochia; Stewart J Levine Journal: Am J Respir Cell Mol Biol Date: 2016-08 Impact factor: 6.914
Authors: Cody E Nichols; John S House; Huiling Li; James M Ward; Annah Wyss; Jason G Williams; Leesa J Deterding; Jennifer A Bradbury; Laura Miller; Darryl C Zeldin; Stephanie J London Journal: Am J Respir Cell Mol Biol Date: 2021-03 Impact factor: 6.914